Both in Biotechnology
Denali Therapeutics vs Adaptive Biotechnologies
Over the past year DNLI returned +38.3% and ADPT returned +54.2%; their daily moves had a correlation of 0.29.
DNLI +38.3% ADPT +54.2%Growth of $1, one year, split-adjusted
| Metric | DNLI | ADPT |
|---|---|---|
| Price | $19.45 | $25.80 |
| Market cap | $3.11B | $4.12B |
| Today | +3.13% | +2.95% |
| 1 month | −2.3% | −13.5% |
| 6 months | +2.8% | +87.2% |
| Year to date | +17.8% | +58.9% |
| 1 year | +19.5% | +48.6% |
| Revenue growth (YoY) | — | +21.5% |
| Gross margin | 97.4% | 71.8% |
| Net margin | −3539.2% | −55.6% |
| P/E (TTM) | — | — |
| Price / sales | 862.7× | 13.4× |
| Net cash | $705.0M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 38.0% | 51.1% |
| Short % of float | 11.6% | 10.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).